Skip to main content

Table 1 Baseline characteristics and comparisons between 24 persons with T2D and 148 persons with T1D

From: Depression differed by midnight cortisol secretion, alexithymia and anxiety between diabetes types: a cross sectional comparison

 

Type 2 diabetes

Type 1 diabetes

P-valuea

N

24

148

 

Age (years)

50 (41, 57; 31–59)

46 (40, 53; 32–59)

0.38b

Gender

Men

12 (50)

83 (56)

0.66

Women

12 (50)

65 (44)

Diabetes duration (years)

11 (7, 14; 2–32)

24 (14, 33; 1–55)

< 0.001b

Depression (HADS-D ≥ 8 p)

6 (25)

17 (12)

0.10

Alexithymia (TAS-20 ≥ 61 p)

6 (25)

19 (13)

0.12

Anxiety (HADS-A ≥ 8 p)

9 (38)

52 (35)

0.82

Physical inactivity

4 (19)

11 (8)

0.10

Smoking

2 (9)

12 (8)

> 0.99

MSC (nmol/L) All measurements

7.8 (5.1, 12.0; 1.9–23.0)

5.2 (3.1, 7.8; 1.9–47.0)

0.006b

MSC (nmol/L) Spring

6.7 (3.6, 11.5; 1.9–13.0)

7.1 (5.2, 10.0; 1.9–31.0)

0.84b

MSC (nmol/L) Summer

7.6 (7.2, 13,5; 6.8–15.0)

4.8 (3.0, 11.0; 2.3–47.0)

0.051b

MSC (nmol/L) Autumn/early winter

8.1 (4.5, 16.2; 3.2–23.0)

3.2 (2.7, 5.4; 1.9–26.0)

0.001b

High MSC (≥ 9.3 nmol/L)

9 (38)

33 (22)

0.13

HbA1c

mmol/mol

60 (49, 75; 41–113)

63 (55, 71; 32–110)

0.78b

%

7.6 (6.6, 9.0; 5.9–12.5)

7.9 (7.2, 8.6; 5.1–12.2)

HbA1c > 70 mmol/mol (> 8.6%)

8 (33)

38 (26)

0.46

BMI (kg/m2) Men

31 (28, 32; 26–34)

25 (23, 28; 18–38)

< 0.001b

BMI (kg/m2) Women

31 (24, 36; 21–39)

24 (23, 27; 18–45)

0.012b

Obesity (BMI ≥ 30 kg/m2)

14 (58)

16 (11)

< 0.001

Inhaled steroids

1 (4)

13 (7)

0.70

Antidepressants

2 (8)

12 (8)

> 0.99

Clinical psychiatric diagnoses

4 (17)

20 (14)

0.54

Foot complications

5 (22)

28 (20)

0.78

Cardiovascular complications

4 (17)

7 (5)

0.049

Diabetes retinopathy

14 (58)

116 (79)

0.039

  1. Data are n (%) or median (q1, q3; range)
  2. aFisher’s exact test unless otherwise specified
  3. bMann - Whitney U test. Missing values T2D/T1D: physical inactivity n = 3/4; smoking n = 2/3; foot complications n = 1/7; diabetes retinopathy n = 0/1